Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

A.I.-Aided Processes Reduce Chemical Reaction Time, Waste

Ryan Hartman

A chemical engineering lab designed processes with artificial intelligence to screen chemical reactions in small quantities that can reduce the time and waste in current methods. . . . → Read More: A.I.-Aided Processes Reduce Chemical Reaction Time, Waste

Companies to Analyze 40,000 Protein Samples

DNAmolcule model

A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples. . . . → Read More: Companies to Analyze 40,000 Protein Samples

Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal

Neurons illustration

Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain. . . . → Read More: Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal

Nanotech Gene Therapy Company Raises $8.5M in Seed Funds

Editing DNA

A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round. . . . → Read More: Nanotech Gene Therapy Company Raises $8.5M in Seed Funds

FDA Clears Mobile App for Opioid Use Disorder

Man with smartphone

The Food and Drug Administration authorized a mobile app, when prescribed by clinicians for patients with opioid use disorder in outpatient treatment programs. . . . → Read More: FDA Clears Mobile App for Opioid Use Disorder

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

RNA Biotech Raises $604M in IPO

NASDAQ share price display

Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million. . . . → Read More: RNA Biotech Raises $604M in IPO

Post-Surgical Opioid Prescriptions Safely Cut

Pills and capsules

A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills. . . . → Read More: Post-Surgical Opioid Prescriptions Safely Cut

Report – 289 Cell and Gene Therapies in Development

Human T-cell

A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration. . . . → Read More: Report – 289 Cell and Gene Therapies in Development

FDA Identifies Database to Evaluate Precision Diagnostics

DNA puzzle

The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine. . . . → Read More: FDA Identifies Database to Evaluate Precision Diagnostics